Pathological Classification of Pulmonary Nodules in Images Using Deep Learning

NCT ID: NCT05221814

Last Updated: 2022-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-01

Study Completion Date

2023-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to develop a deep-learning model to automatically classify pulmonary nodules based on white-light images and to evaluate the model performance. Besides, suitable operation could be chosen with the help of this model, which could shorten the time of surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All white-light photographs of pulmonary nodules from phones of pathologically confirmed adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) were retrospectively collected from consecutive patients who underwent surgery between June 30, 2020 and September 15, 2021 at Guangdong Provincial People's Hospital.Finally, a total of 1037 white-light images from 973 individuals were included in the study. The entire dataset was divided into training and test datasets, which were mutually exclusive, using random sampling. Of these, 830 images were used as the training dataset and 104 images from were used as the test dataset. The CNN model was used in classifying images, namely, Resnet-50. For the CNN model, pretrained model with the ImageNet Dataset were adopted using transfer learning. After constructing the CNN models using the training dataset, the performance of the models was evaluated using the test dataset and the prospective validation dataset.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Artificial Intelligence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

gross pathologic photo based deep learning model

Whether apply gross pathologic photo based deep learning model to predict pathologic subtype

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female,18 years and older.
2. Patients haven't undergone any therapy.
3. The pulmonary nodules were confirmed AIS, MIA or IAC.
4. The sizes of pulmonary nodules were less than 3cm.
5. The images were jpg format.

Exclusion Criteria

1. Suffering from other tumor disease before or at the same time.
2. Images with poor quality or low resolution that precluded proper classification.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Guangdong Provincial People's Hospital

OTHER

Sponsor Role collaborator

Jiangxi Provincial Cancer Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Haiyu Zhou

vice-president

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Haiyu Zhou

Role: PRINCIPAL_INVESTIGATOR

Guangdong Provincial People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Guagndong Provincial People's Hospital

Guangzhou, Guangdong, China

Site Status RECRUITING

Jiangxi Cancer Hospital

Nanchang, Jiangxi, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Haiyu Zhou

Role: CONTACT

+8613710342002

Shaowei Wu

Role: CONTACT

+8613411965219

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Haiyu Zhou, PhD

Role: primary

*8613710342002

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021ky228

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Retrospective Pathology Foundation Models
NCT07239297 ENROLLING_BY_INVITATION
AI Determine Malignancy of GGO on Chest CT
NCT06282068 ENROLLING_BY_INVITATION